Русская версия English version   
О журнале
Редакционная коллегия
Правила для авторов
Информация для читателей и авторов
Оглавление текущего номера
Архив
Контакты
Поиск

Отправить статью
 


Том 20   Выпуск 1   Год 2025
Список литературы

  1. Serra S. Recent developments in the synthesis of the flavors and fragrances of terpenoid origin. Stud. Nat. Prod. Chem. 2015;46:201–226. doi: 10.1016/B978-0-444-63462-7.00007-5
  2. Manina A.S., Forlani F. Biotechnologies in perfume manufacturing: Metabolic engineering of terpenoid biosynthesis. Int. J. Mol. Sci. 2023;24. Article No. 7874. doi: 10.3390/ijms24097874
  3. Cao X., Yu W., Chen Y., Yang S., Zhao Z.K., Nielsen J., Luan H., Zhou Y.J. Engineering yeast for high-level production of diterpenoid sclareol. Metab. Eng. 2023;75:19–28. doi: 10.1016/j.ymben.2022.11.002
  4. Maurya R., Patel H., Bhatt D., Shakhreliya S., Gohil N., Bhattacharjee G., Malviya N., Desai M. Microbial production of natural flavors and fragrances. In: Recent Advances in Food Biotechnology. Singapore: Springer Nature Singapore. 2022:139–159. doi: 10.1007/978-981-16-8125-7_7
  5. Öğütçü H., Sökmen A., Sökmen M., Polissiou M., Serkedjieva J., Daferera D., Tepe B. Bioactivities of the various extracts and essential oils of Salvia limbata C.A. Mey. and Salvia sclarea L. Turk. J. Biol. 2008;32:181–192.
  6. Raafat K., Habib J. Phytochemical compositions and antidiabetic potentials of Salvia sclarea L. essential oils. J. Oleo Sci. 2018;67:1015–1025. doi: 10.5650/jos.ess17187
  7. Zhou J., Xie X., Tang H., Peng C., Peng F. The bioactivities of sclareol: A mini review. Front. Pharmacol. 2022;13. Article No. 1014105. doi: 10.3389/fphar.2022.1014105
  8. Chalvin C., Drevensek S., Gilard F., Mauve C., Chollet C., Morin H., Hernould M., Bergougnoux V. Sclareol and linalyl acetate are produced by glandular trichomes through the MEP pathway. Hortic. Res. 2021;8. Article No. 206. doi: 10.1038/s41438-021-00640-w
  9. Aćimović M., Kiprovski B., Rat M., Sikora V., Popović V., Koren A., Vuković P. Salvia sclarea: Chemical composition and biological activity. J. Agron. Technol. Eng. Manag. 2018;1:18–28.
  10. Pironti C., Ricciardi M., Proto A., Bianco P.M., Montano L., Motta O. Endocrine-disrupting compounds: An overview on their occurrence in the aquatic environment and human exposure. Water. 2021;13. Article No. 1347. doi: 10.3390/w13101347
  11. Darbre P.D. Chemical components of plastics as endocrine disruptors: Overview and commentary. Birth Defects Res. 2020;112:1300–1307. doi: 10.1002/bdr2.1778
  12. Satpathy R. Application of molecular docking methods on endocrine disrupting chemicals: A review. J. Appl. Biotechnol. Rep. 2020;7:74–80. doi: 10.30491/jabr.2020.108287
  13. Metcalfe C.D., Bayen S., Desrosiers M., Muñoz G., Sauvé S., Yargeau V. An introduction to the sources, fate, occurrence and effects of endocrine disrupting chemicals released into the environment. Environ. Res. 2022;207. Article No. 112658. doi: 10.1016/j.envres.2021.112658
  14. Kazemi Z., Aboutaleb E., Shahsavani A., Kermani M., Kazemi Z. Evaluation of pollutants in perfumes, colognes and health effects on the consumer: A systematic review. J. Environ. Health Sci. Eng. 2022;20:589–598. doi: 10.1007/s40201-021-00783-x
  15. Halios C.H., Landeg-Cox C., Lowther S.D., Middleton A., Marczylo T., Dimitroulopoulou S. Chemicals in European residences–Part I: A review of emissions, concentrations and health effects of volatile organic compounds (VOCs). Sci. Total Environ. 2022;839. Article No. 156201. doi: 10.1016/j.scitotenv.2022.156201
  16. Ripamonti E., Allifranchini E., Todeschi S., Bocchietto E. Endocrine disruption by mixtures in topical consumer products. Cosmetics. 2018;5:61. doi: 10.3390/cosmetics5040061
  17. Buckley J.P., Herring A.H., Wolff M.S., Calafat A.M., Engel S.M. Prenatal exposure to environmental phenols and childhood fat mass in the Mount Sinai children’s environmental health study. Environ. Int. 2016;91:350–356. doi: 10.1016/j.envint.2016.03.019
  18. Meng M., Yang Y., Song L., Peng J., Li S., Gao Z., Liu X., Zhang Y. Association between urinary phthalates and phthalate metabolites and cancer risk: A systematic review and meta-analysis. Heliyon. 2024;10. Article No. e29684. doi: 10.1016/j.heliyon.2024.e29684
  19. Costa H.E., Cairrao E. Effect of bisphenol A on the neurological system: A review update. Arch. Toxicol. 2024;98:1–73. doi: 10.1007/s00204-023-03614-0
  20. Martín-Pozo L., Gómez-Regalado M.D.C., Moscoso-Ruiz I., Zafra-Gómez A. Analytical methods for the determination of endocrine disrupting chemicals in cosmetics and personal care products: A review. Talanta. 2021;234. Article No. 122642. doi: 10.1016/j.talanta.2021.122642
  21. Di Dalmazi G., Giuliani C. Plant constituents and thyroid: A revision of the main phytochemicals that interfere with thyroid function. Food Chem. Toxicol. 2021;152. Article No. 112158. doi: 10.1016/j.fct.2021.112158
  22. Sarma I., Gowala U., Misra K., Saikia A., Saikia A.J., Namchoom K., Sarma H.N. Beneficial endocrine disruption as steroid receptor functional modulator by phytocompounds from medicinally important plants: Impact on female reproduction regulation. Proc. Zool. Soc. 2021;74:408–416. doi: 10.1007/s12595-021-00404-3
  23. Oliveira K.J., Chiamolera M.I., Giannocco G., Pazos-Moura C.C., Ortiga-Carvalho T.M. Thyroid function disruptors: From nature to chemicals. J. Mol. Endocrinol. 2018;62. P. R1–R19. doi: 10.1530/JME-18-0081
  24. Pistollato F., Masias M., Agudo P., Giampieri F., Battino M. Effects of phytochemicals on thyroid function and their possible role in thyroid disease. Ann. N. Y. Acad. Sci. 2019;1443:3–19. doi: 10.1111/nyas.13980
  25. Aćimović M., Kiprovski B., Rat M., Sikora V., Popović V., Koren A., Brdar-Jokanovic M.D. Salvia sclarea: Chemical composition and biological activity. J. Agron. Technol. Eng. Manag. 2018;1:18–28.
  26. Kabier M., Gambacorta N., Trisciuzzi D., Kumar S., Nicolotti O., Mathew B. MzDOCK: A free ready-to-use GUI-based pipeline for molecular docking simulations. J. Comput. Chem. 2024;45:1980–1986. doi: 10.1002/jcc.27390
  27. Koes D.R., Baumgartner M.P., Camacho C.J. Lessons learned in empirical scoring with smina from the CSAR 2011 benchmarking exercise. J. Chem. Inf. Model. 2013;53(8):1893–1904. doi: 10.1021/ci300604z
  28. Bhojwani H.R., Joshi U.J. Pharmacophore and docking guided virtual screening study for discovery of type I inhibitors of VEGFR-2 kinase. Curr. Comput. Aided Drug Des. 2017;13:186–207. doi: 10.2174/1386207319666161214112536
  29. Rossino G., Rui M., Pozzetti L., Schepmann D., Wünsch B., Zampieri D., Pellavio G., Laforenza U., Rinaldi S., Colomboet G. et al. Setup and validation of a reliable docking protocol for the development of neuroprotective agents by targeting the sigma-1 receptor (S1R). Int. J. Mol. Sci. 2020;21. Article No. 7708. doi: 10.3390/ijms21207708
  30. Land H., Humble M.S. YASARA: A tool to obtain structural guidance in biocatalytic investigations. Methods Mol. Biol. 2018;1685:43–67. doi: 10.1007/978-1-4939-7366-8_4
  31. Patel C.N., Kumar S.P., Pandya H.A., Rawal R.M. Identification of potential inhibitors of coronavirus hemagglutinin-esterase using molecular docking, molecular dynamics simulation, and binding free energy calculation. Mol. Divers. 2021;25:421–433. doi: 10.1007/s11030-020-10135-w
  32. Odhar H.A., Hashim A.F., Ahjel S.W., Humadi S.S. Molecular docking and dynamics simulation analysis of the human FXIIa with compounds from the Mcule database. Bioinformation. 2023;19:160–166. doi: 10.6026/97320630019160
  33. Aris S.N.A.M., Rahman M.Z.A., Rahman R.N.Z.R.A., Ali M.S.M., Salleh A.B., Teo C.Y., Leow T.C. Identification of potential riboflavin synthase inhibitors by virtual screening and molecular dynamics simulation studies. J. King Saud Univ. Sci. 2021;33. Article No. 101270. doi: 10.1016/j.jksus.2020.101270
  34. Krieger E., Vriend G. New ways to boost molecular dynamics simulations. J. Comput. Chem. 2015;36:996–1007. doi: 10.1002/jcc.23899
  35. Rampogu S., Lee G., Park J.S., Lee K.W., Kim M.O. Molecular docking and molecular dynamics simulations discover curcumin analogue as a plausible dual inhibitor for SARS-CoV-2. Int. J. Mol. Sci. 2022;23. Article No. 1771. doi: 10.3390/ijms23031771
  36. Cino E.A., Choy W.Y., Karttunen M. Comparison of secondary structure formation using 10 different force fields in microsecond molecular dynamics simulations. J. Chem. Theory Comput. 2012;8:2725–2740. doi: 10.1021/ct300323g
  37. Weiss M.S., Brandl M., Sühnel J., Pal D., Hilgenfeld R. More hydrogen bonds for the (structural) biologist. Trends Biochem. Sci. 2001;26:521–523. doi: 10.1016/S0968-0004(01)01935-1
  38. Fatriansyah J.F., Boanerges A.G., Kurnianto S.R., Pradana A.F., Fadilah S.S.N., Surip S.N. Molecular Dynamics simulation of ligands from Anredera cordifolia (Binahong) to the main protease (Mpro) of SARS-CoV-2. J. Trop. Med. 2022;2022. Article No. 1178228. doi: 10.1155/2022/1178228
  39. Srinivasan E., Rajasekaran R. Computational investigation of curcumin, a natural polyphenol that inhibits the destabilization and the aggregation of human SOD1 mutant (Ala4Val). RSC Adv. 2016;6:102744–102753. doi: 10.1039/C6RA21927F
  40. Swanson J.M.J., Henchman R.H., McCammon J.A. Revisiting free energy calculations: A theoretical connection to MM/PBSA and direct calculation of the association free energy. Biophys. J. 2004;86:67–74. doi: 10.1016/S0006-3495(04)74084-9
  41. Lovering A.L., Lee S.S., Kim Y.W., Withers S.G., Strynadka N.C.J. Mechanistic and structural analysis of a family 31 alpha-glycosidase and its glycosyl-enzyme intermediate. J. Biol. Chem. 2005;280(3):2105–2115. doi: 10.1074/jbc.M410468200
  42. Bepari A.K., Reza H.M. Identification of a novel inhibitor of SARS-CoV-2 3CL-PRO through virtual screening and molecular dynamics simulation. PeerJ. 2021;9. Article No. e11261. doi: 10.7717/peerj.11261
  43. Guerrero-Bosagna C.M., Skinner M.K. Environmental epigenetics and phytoestrogen/phytochemical exposures. J. Steroid Biochem. Mol. Biol. 2014;139:270–276. doi: 10.1016/j.jsbmb.2012.12.011
  44. Al Zarzour R.H., Kamarulzaman E.E., Saqallah F.G., Zakaria F., Asif M., Abdul Razak K.N.A. Medicinal plants’ proposed nanocomposites for the management of endocrine disorders. Heliyon. 2022;8. Article No. e10665. doi: 10.1016/j.heliyon.2022.e10665
  45. Domínguez-López I., Yago-Aragón M., Salas-Huetos A., Tresserra-Rimbau A., Hurtado-Barroso S. Effects of dietary phytoestrogens on hormones throughout a human lifespan: A review. Nutrients. 2020;12. Article No. 2456. doi: 10.3390/nu12082456
  46. Tsai S.W., Hsieh M.C., Li S., Lin S.C., Wang S.P., Lehman C.W., Lien C.Z., Lin C.-C. Therapeutic potential of sclareol in experimental models of rheumatoid arthritis. Int. J. Mol. Sci. 2018;19. Article No. 1351. doi: 10.3390/ijms19051351
  47. Stepanović A., Terzić Jovanović N.T., Korać A., Zlatović M., Nikolić I., Opsenica I., Pešić M. Novel hybrid compounds of sclareol and doxorubicin as potential anticancer nanotherapy for glioblastoma. Biomed. Pharmacother. 2024;174. Article No. 116496. doi: 10.1016/j.biopha.2024.116496
  48. Marrelli M., Amodeo V., Perri M.R., Conforti F., Statti G. Essential oils and bioactive components against arthritis: A novel perspective on their therapeutic potential. Plants. 2020;9. Article No. 1252. doi: 10.3390/plants9101252
  49. Aljelehawy Q.H.A., Mohammadi S., Mohamadian E., Allah R.M., Mirzaei A., Ghahremanlou M. Antimicrobial, anticancer, antidiabetic, antineurodegenerative, and antirheumatic activities of thymol: Clarification of mechanisms. Micro Nano Bio Aspects. 2023;2:1–7. doi: 10.22034/MNBA.2023.381107.1019
  50. Ma H., Steede T., Dewey R.E., Lewis R.S. Engineering sclareol production on the leaf surface of Nicotiana tabacum. J. Agric. Food Chem. 2024;72:13812–13823. doi: 10.1021/acs.jafc.4c02442
  51. Michailidou F. The scent of change: Sustainable fragrances through industrial biotechnology. ChemBioChem. 2023;24. Article No. e202300309. doi: 10.1002/cbic.202300309
  52. Chibuogwu I.C., Nwannenna A.I., Ogwu D., Garba M., Ubah S.A., Ajayi I.E. Endocrine disruptors in Adansonia digitata (Linn) extract induce alteration of female Wistar rats’ oestrous cycle, hormone and lipid profiles. Gen. Comp. Endocrinol. 2023;344. Article No. 114385. doi: 10.1016/j.ygcen.2023.114385
  53. Alagarsamy V., Sundar P.S., Solomon V.R., Murugesan S., Muzaffar-Ur-Rehman M., Kulkarni V.S., Sulthana M.T., Narendhar B., Sabarees G. Computational screening of some phytochemicals to identify best modulators for ligand binding domain of estrogen receptor alpha. Curr. Pharm. Des. 2024;30:1599–1609. doi: 10.2174/0113816128287431240408045732
Содержание
Оригинальная статья
Satpathy R., Padhan P., Behera R., Ratha J. Investigating the Endocrine Disruption Potential of Sclareol through Docking and Molecular Dynamics Simulation Methods . Маthematical biology and bioinformatics. 2025;20(1):122-134. doi: 10.17537/2025.20.122
(опубликована на англ. яз.)

Аннотация (англ.)
Аннотация (рус.)
Полный текст (англ., pdf)
Список литературы

 
  Copyright ИМПБ РАН © 2005-2026